Company Name: Immunomedics, Inc.    

Immunomedics, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of monoclonal antibody-based therapeutics for cancer, autoimmune disorders and other serious diseases.

Ticker Symbol: IMMU (NASDAQ)

Company Website: www.immunomedics.com

Social Media: Immunomedics LinkedIn

Headquarters: Morris Plains, NJ